Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome(®) and AmBisome(®) in murine cutaneous leishmaniasis

Fungisome(®) (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effective therapeutic for the parasitic infection visceral leishmaniasis. Its potential in the treatment of cutaneous leishmaniasis (CL), a disfiguring form of the disease affecting the skin, is currently...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Parasitol Drugs Drug Resist
Main Authors: Wijnant, Gert-Jan, Van Bocxlaer, Katrien, Yardley, Vanessa, Harris, Andy, Alavijeh, Mo, Silva-Pedrosa, Rita, Antunes, Sandra, Mauricio, Isabel, Murdan, Sudaxshina, Croft, Simon L.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039306/
https://ncbi.nlm.nih.gov/pubmed/29673889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2018.04.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki